ABVC BioPharma, Inc. (ABVC) Total liabilities 2018–2025
ABVC BioPharma, Inc. (ABVC) total liabilities at each fiscal year-end, per SEC filings.
$7.8MFY2025 · since FY2018: $11.3M → $7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.8M | +13.9% |
| FY2024 | $6.8M | +4.4% |
| FY2023 | $6.5M | +3.0% |
| FY2022 | $6.3M | +31.4% |
| FY2021 | $4.8M | -46.0% |
| FY2020 | $8.9M | +26.8% |
| FY2019 | $7.1M | -37.5% |
| FY2018 | $11.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice